Morgan Stanley is missing from the latest line-up of banks appointed to lead the €500m ($592m) initial public offering for Probitas Pharma, the Spanish bio-pharmaceutical group. It had been one of four banks selected to float the company three years ago.

Banco Bilbao Vizcaya Argentaria, Deutsche Bank and Santander Central Hispano - have all been reappointed.